skip to main content

H.R. 4392 (115th): To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Nov 14, 2017.

This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.